Nitroprusside ameliorates lung allograft reperfusion injury.

[1]  J. Cooper,et al.  Inhaled nitric oxide improves lung allograft function after prolonged storage. , 1996, The Journal of thoracic and cardiovascular surgery.

[2]  J. Cooper,et al.  Inhaled nitric oxide reduces human lung allograft dysfunction. , 1996, The Journal of thoracic and cardiovascular surgery.

[3]  G. Patterson,et al.  Free radical-mediated vascular injury in lungs preserved at moderate hypothermia. , 1995, The Annals of thoracic surgery.

[4]  J. Willerson,et al.  Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. , 1995, Circulation.

[5]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[6]  M. Oz,et al.  Nitroglycerin maintains graft vascular homeostasis and enhances preservation in an orthotopic rat lung transplant model. , 1995, The Journal of thoracic and cardiovascular surgery.

[7]  M. Oz,et al.  The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. M. Lefer,et al.  Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. , 1994, The American journal of physiology.

[9]  P. Kubes,et al.  NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. , 1994, The American journal of physiology.

[10]  G. Patterson,et al.  Pentoxifylline reduces lung allograft reperfusion injury. , 1994, The Annals of thoracic surgery.

[11]  M. Oz,et al.  Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. , 1994, The Journal of clinical investigation.

[12]  R. McIntyre,et al.  Cold ischemia and reperfusion each produce pulmonary vasomotor dysfunction in the transplanted lung. , 1993, The Journal of thoracic and cardiovascular surgery.

[13]  S. Steen,et al.  Endothelium-dependent relaxation in pulmonary arteries after lung preservation and transplantation. , 1993, The Annals of thoracic surgery.

[14]  P. Kubes,et al.  Nitric oxide prevents leukocyte adherence: role of superoxide. , 1993, The American journal of physiology.

[15]  P. Kubes,et al.  Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. , 1993, The American journal of physiology.

[16]  B. Wilcox,et al.  Effect of a free radical scavenger on cadaver lung transplantation. , 1993, The Annals of thoracic surgery.

[17]  P. Kubes,et al.  Nitric oxide modulates microvascular permeability. , 1992, The American journal of physiology.

[18]  W. Jamieson,et al.  Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation. , 1991, The Annals of thoracic surgery.

[19]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[20]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[22]  G. Mandell.  ARDS, neutrophils, and pentoxifylline. , 1988, The American review of respiratory disease.

[23]  M. Feelisch,et al.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. , 1987, European journal of pharmacology.

[24]  L. Ignarro,et al.  Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. , 1986, The Journal of pharmacology and experimental therapeutics.

[25]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[26]  J. McCord,et al.  Oxygen-derived free radicals in postischemic tissue injury. , 1985, The New England journal of medicine.